Skip to main content
Close Search
BIVDA Newsletter
search
Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive
  • search
Mar 19 2026
Love0

EU Safe and Sustainable by Design framework

By admin Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive
We are writing to update you that the European Commission adopted on 6 March 2026 the revised recommendation on the Safe and Sustainable by Design (SSbD) framework. For background: The initiative was first announced in the 2020 Chemicals Strategy for Sustainability. The framework builds on the 2022 Commission Recommendation, followed by a testing phase and stakeholder engagement involving Member States, industry, academic…
Read More
March 13, 2026 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For Review by 18 March: Weekly ECHA Substance Evaluations

Dear Members, please see the latest MedTech Europe ECHA CLP update. If Any of these are used in your products, please let me know at regulatory@bivda.org.uk With this email, we would like to inform you about the latest chemical developments at ECHA and kindly ask you to indicate if any of the following impact your company by 18 March. CLP…
Read More
February 20, 2026 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For Review by 25 February: Weekly ECHA Substance Evaluations

Dear members, please see the latest MedTech Europe update on the weekly ECHA news. If you impacted by any of these reviews, then please let me know at regulatory@bivda.org.uk With this email, we would like to inform you about the latest chemical developments at ECHA and kindly ask you to indicate if any of the following impact your company by…
Read More
December 12, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

MedTech Europe Input – POPs

Dear members, please let me have any feedback at regulatory@bivda.org.uk  regarding the below update from MedTech Europe  on the inclusion of MCCP to the UN Convention and EU POPs legislation. In principle I’m happy to support the MedTech Europe position re: MCCP We are writing to invite you to share input by 9 January 2026 EOB to an action from the…
Read More
December 11, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

MedTech Europe – EU Bioeconomy

Please be informed that the European Commission has adopted a new Strategic Framework for a Competitive and Sustainable EU Bioeconomy, to build a clean, competitive and resilient European economy. By using renewable biological resources from land and sea and providing alternatives to critical raw materials, the EU aims at moving forward towards a more circular and decarbonised economy and can decrease dependence on…
Read More
December 11, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

MedTech Europe – chemicals under review by ECHA

Dear Members, please see below update from MedTech Europe on Chemicals being reviewed by ECHA. f you use, or have these chemicals in your products please let me know at regulatory@bivda.org.uk   sodium bromide (CAS 7647-15-6, EC 231-599-9). Proposed classification: Repr. 1B, Lact., STOT SE 3, STOT RE 1   potassium bromide (CAS 7758-02-3, EC 231-830-3) Proposed classification: Repr. 1B,…
Read More
December 10, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

EU ECO Design Regulation Implementation impacting External Power Supplies

Dear members, please see below notification regarding EU ECO Design Regulation Implementation impacting External Power Supplies Note that although External Powers Supplies designed, tested and exclusively marketed for use with medical devices are exempt, External Power Supplies associated with off the shelf IT equipment are not, this includes Off the shelf equipment supplied with IVDs, especially if imported from outside…
Read More
November 13, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For review by 19 November: Weekly ECHA Substance Evaluations

From MedTech Europe - please provide any comments to neil.plumridge@bivda.org.uk. With this email, we would like to inform you about the latest chemical developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 19 November. Please note that the substances highlighted in yellow are the ones already present in the substance tracker…
Read More
November 13, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

EU Biocides – Ethanol CMR Classification impact

Dear Members, please see the update below from MedTech Europe on the CMR classification of Ethanol, and the current review under the EU Biocides legislation. Note that the final decision will also impact Northern Ireland. This could impact both the availability of ethanol-based hand disinfectants and the use of ethanol-based disinfectants more widely, although one option will be for the…
Read More
November 13, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For information: ECHA PFAS sectors & uses mapping

Dear Members, please see below update on the current stage of the EU proposed PFAS restriction We are writing to share with you the ECHA PFAS mapping of which uses fall under which sector (at the link here) which was just made available by ECHA. Background: In the recent September ECHA PFAS plenary and in the 30 October ECHA webinar on…
Read More
October 31, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For review by 5 November: Weekly ECHA Substance Evaluations

Dear Members , MedTech Europe chemicals update. Let me know if the below update impacts you, so we can monitor accordingly. With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 5 November. Please note that the substances highlighted…
Read More
October 31, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

Launch of the EU Critical Chemicals Alliance

Dear Members, please see below update from MedTech Europe The European Commission launched the 'EU Critical Chemicals Alliance' (link). Background: The recent EU Chemicals Industry Action Plan released a few months ago, indicated that such a platform would be launched, in order to support the chemical sector in view of the challenges they are facing (e.g. high energy prices, etc.) and…
Read More
October 31, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

UPDATE: For information: ECHA webinar on PFAS SEAC Consultation

Dear members, please see below update on EU progress with the proposed restriction of PFAS substances. Dear members, We are reaching out to follow up on the email below and provide an update regarding the ECHA webinar on the PFAS SEAC draft opinion consultation, which took place today. The webinar presented information on how to prepare for, and what to…
Read More
September 22, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For review by 24 September: Weekly ECHA Substance Evaluations

Please see MedTech Europe Update below, if your impacted by these changes please let me know at regulatory@bivda.org.uk With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 24 September. Please note that the substances highlighted in yellow are…
Read More
September 22, 2025 in Environmental Newsletter, Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For review: PFAS additional timelines

Dear members, please see below update regarding the ECHA review PFAS substances. If you wish to provide feedback, please email me at regulatory@bivda.org.uk We are writing to inform you that following today's ECHA PFAS discussion in the Socio-Economic Impact Assessment Committee (SEAC), ECHA has just published a press release outlining the following additional timelines (link): ECHA's RAC/SEAC committees plan to…
Read More
August 28, 2025 in Environmental Newsletter Archive, MedTech Europe Updates Environmental Newsletter, MedTech Europe Updates Environmental Newsletter Archive

For Review by 3 September: Weekly ECHA Substance Evaluations

Dear Members, please see below update from MedTech Europe, let me know at regulatory@bivda.org.uk if any of these impact you. Items highlighted have previously been flagged as chemicals in use by the MD/IVD sector. With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the…
Read More

Email us
membership@bivda.org.uk

Call us
+44 (0) 333 3208 823

Website
www.bivda.org.uk

Find us
299 Oxford Street (5th floor)
London, W1C 2DZ

© Copyright 2026 BIVDA Ltd is registered in England, with Company Number 2687137 Registered Office is 299 Oxford Street (5th floor), London, W1C 2DZ. VAT Number 563105858
Web Design by WDAT

  • twitter
  • linkedin
Close Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive